The Company confirms that its trading performance to date and expectations for 2019 are in line with the guidance provided in its 7 June 2019 trading update. Accordingly, the Company expectation to deliver 2019 revenues of approximately US $87m, EBITDA of approximately US $28m, and expects to have net cash at 31 December 2019 of approximately US $18m remains unchanged.
Back to All News
All Market News
Other Market News
Murray Income Trust Half-Year Financial Report
CQS New City High Yield Fund – Interim Report
London Stock Exchange Group Publish Final Results
GSK Release Linerixibat Update
GSK Release Bepirovirsen Update
ASML Publishes 2025 Annual Reports
Sign up for our Stock News Highlights
Delivered to your inbox every Friday